Analyst Research Report Snapshot

Title:

BASILEA - ISA INTEREST INTENSIFIES

Price:

$10.00

Provider:

Edison Investment Research

Date:

08 Feb 2013

Pages:

2

Type:

AcrobatPDF

Companies referenced:

BSLN.S

Available for Immediate Download
Summary:

Pivotal isavuconazole data in H213 could reinvigorate investor attention and pave the way for filing in 2014. In addition, progress with the early stage pipeline continues. Although uncertainties remain around ceftobiprole, management’s commitment to partnering rather than conducting further clinical trials is encouraging. The strong cash position reported with 2012 financial results underpins 70% of the current market cap, providing downside protection.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.